Wheeler Bio, Inc., a clinical contract development and manufacturing organization (CDMO), appointed Stewart McNaull Chief Business Officer. Stewart will be leading the commercialization of Wheeler’s tech platform – Portable CMC – to rapidly advance biologics programs from discovery to clinical leads. McNaull most recently served as Business Unit Head, Biologics and Vaccines at Resilience where he had global responsibility for the Resilience franchise, entailing development and execution of sa...